JEREMY SCHMIDT: Open Payments
NPI 1184892622 · NEW BRAUNFELS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$23,444 in 188 payments from 30 companies in 2025. Trend: 2023 $33,577 · 2024 $21,383 · 2025 $23,444
Speaker / faculty: $16,319Food & beverage: $4,035Travel & lodging: $3,090
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 32 | $12,013 |
| Lilly USA, LLC | 28 | $8,632 |
| Bayer Healthcare Pharmaceuticals Inc. | 20 | $351 |
| Corcept Therapeutics | 10 | $296 |
| Amgen Inc. | 11 | $233 |
| Madrigal Pharmaceuticals | 4 | $185 |
| Dexcom, Inc. | 5 | $172 |
| RECORDATI_RARE_DISEASES_INC. | 10 | $166 |
| Esperion Therapeutics, Inc. | 9 | $150 |
| Amneal Pharmaceuticals LLC | 9 | $145 |
Products named: Ozempic, MOUNJARO, Kerendia, JARDIANCE, Korlym, Wegovy, REZDIFFRA, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
